Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RGEN · against 454 other Healthcare companies listed in US-listed
Ranked #145 of 455 · scores higher than 67% of peers
Bars: peers in each 10-point band of the growth score66 peers with a growth score of 80–89, including RGEN · Click a bar to see the companies
Mainly thanks to its earnings per share growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | RGEN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 16.5% | 11.0% | 60% | 33% | |
| Earnings per share growthHigher is better · 171 reported | Not reported | 21.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 433 reported | 3.3% | 11.0% | 28% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 145 | Unavailable | 80 | 56 | |
| 145 | 14.6B USD | 80 | 59 | |
| 145 | 14.9B USD | 80 | 65 | |
| 145 | 9.0B USD | 80 | 78 | |
| 145 | 10.1B USD | 80 | 61 | |
| 152 | 449M USD | 79 | 72 | |
| 152 | 13.7B USD | 79 | 45 | |
| 152 | 5.8B USD | 79 | 64 | |
| 152 | 1.5B USD | 79 | 43 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score